Enliven Therapeutics
ELVN
#4912
Rank
S$2.20 B
Marketcap
S$36.85
Share price
-6.16%
Change (1 day)
33.82%
Change (1 year)

Market capitalization of Enliven Therapeutics (ELVN)

Market cap: S$2.20 Billion

As of March 2026 Enliven Therapeutics has a market cap of S$2.20 Billion. This makes Enliven Therapeutics the world's 4912th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Enliven Therapeutics from 2023 to 2026

End of year Market Cap

Year Marketcap Change
2026S$2.20 B77.44%
2025S$1.24 B-16.4%
2024S$1.48 B97.22%
2023S$0.75 B

End of Day market cap according to different sources

On Mar 11th, 2026 the market cap of Enliven Therapeutics was reported to be:

S$2.34 Billion
by Nasdaq info icon info icon
S$2.34 Billion
by CompaniesMarketCap info icon info icon